isomethyleugenol has been researched along with Dystocia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carette, JE; Casey, KM; Cheng, X; Cowan, T; Dai, S; Diep, J; Elias, JE; Gozani, O; Horton, JR; Li, TM; Liu, C; Liu, S; Mak, J; Nagamine, CM; Ooi, YS; Ruppel, KM; Song, D; Spudich, JA; Trivedi, DV; Vilches-Moure, JG; Wilkinson, AW; Zhang, X | 1 |
1 other study(ies) available for isomethyleugenol and Dystocia
| Article | Year |
|---|---|
SETD3 is an actin histidine methyltransferase that prevents primary dystocia.
Topics: Actins; Animals; Cell Line; Dystocia; Female; Histidine; Histone Methyltransferases; Histones; Litter Size; Male; Methylation; Methyltransferases; Mice; Models, Molecular; Muscle, Smooth; Pregnancy; Proteomics; Uterine Contraction; Uterus | 2019 |